Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00921687 · ClinicalTrials.gov registry record · NA
Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study
A NA study, sponsored by Louis Stokes VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 781
- Enrollment target
NCT00921687: Completed NA study, sponsored by Louis Stokes VA Medical Center.
NCT00921687 is a NA study that has completed, run by Louis Stokes VA Medical Center. The registered enrollment target is 781 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00921687, a NA study, has completed, sponsored by Louis Stokes VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 781 participants
- Enrollment target
Study Summary
Chronic kidney disease (CKD) is defined as kidney damage for greater than 3 months or a glomerular filtration rate less than 60 mL/min per 1.73m2 for greater than 3 months. Patients with CKD are at high risk for development of cardiovascular disease and metabolic complications. Guidelines for the care of patients with CKD have been developed by the National Kidney Foundation. Despite the wide availability of these guidelines, adherence is low. The goal of the current study is to evaluate whether a multifactorial intervention, including a CKD registry, will improve CKD guideline adherence. The hypothesis is that providers exposed to a multifactorial clinical intervention including education, academic detailing, and a CKD registry will be more likely to adhere to CKD guidelines than those only exposed to education.
Primary Outcome
Probability for having a PTH measured during the study period comparing intervention vs control clinic during the study period as estimated by Generalized Estimating Equation (determines probability, not proportion). Participants assigned 1 if PTH was measured and 0 if PTH was not measured during the study period.
Interventions
- BEHAVIORAL Education only
- BEHAVIORAL Multifactorial intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 781 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT00921687 record still lists
NCT00921687 is an interventional study that assigns participants to a tested intervention. The registered 781 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 2 interventions - of which Education only is the first listed.
NCT00921687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00921687 about?
NCT00921687 is a clinical study titled "Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement Study". Chronic kidney disease (CKD) is defined as kidney damage for greater than 3 months or a glomerular filtration rate less than 60 mL/min per 1.73m2 for greater than 3 months. Patients with CKD are at high risk for development of cardiovascular disease and metabolic complications. Guidelines for the ca...
What is the current status of trial NCT00921687?
This trial is currently completed. It is a NA study. The enrollment target is 781 participants. The study started on 2009-07. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00921687?
The interventions under investigation include: Education only (BEHAVIORAL), Multifactorial intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00921687?
This trial is sponsored by Louis Stokes VA Medical Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00921687's enrollment target sits among peer trials
781 141st of 2000 higher than 1,860 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- NCT05513872 · 780 participants · Phase 1
Overcoming Nicotine Dependence to Enable Quitting
- NCT06310031 · 780 participants · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia